Triple-negative accounts for about 15 percent of cases of breast cancer.
Tecentriq will accompany the usual treatment of chemotherapy and will help increase the immune system's ability to find and kill cancer cells, according to the AP.
Nine hundred women were studied for the Tecentriq treatment.
Those who had the drug had two months where cancer didn’t get worse, compared to patients who just had chemotherapy. But there were side effects with the combination treatment, including nerve pain and nausea.
For more on how the drug was tested, click here.
Tecentriq costs about $13,400 a month, the AP reported.
Credit: American Cancer Society/Getty Images
Credit: American Cancer Society/Getty Images
In Other News
1
The Latest | World leaders call on Iran and Israel to avoid allowing...
2
Kansas has a new anti-DEI law, but the governor has vetoed bills on...
3
Live video of man who set himself on fire outside court proves...
4
Tennessee Volkswagen workers vote on union membership in test of UAW's...
5
Idaho group says it is exploring a ballot initiative for abortion...
About the Author